State-of-the-Art Neurologic Disease in Italy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 17680
Special Issue Editor
Interests: genetics; chemistry pharmacology; toxicology; Alzheimer; neurodegenerative disease; parkinson’s disease; dementia; stem cells; amyloid; regenerative medicine; dopamine
Special Issue Information
Dear Colleagues,
The aim of this Special Issue is to provide a state-of-the-art review on the current knowledge and management of psychiatric and neurologic diseases in Italy, including aspects related to the molecular effects of COVID‐19 pandemic on brain functions in Italy.
The purpose is to share evidence concerning the most recent development and perspectives in research and clinical management of patients with brain disorders, such as stroke and other neurologic conditions involving the central nervous system and peripheral nerves, as well as psychiatric disorders and neurodegenerative diseases.
Neurologists, neuropsychiatrists, psychologists and basic research scientists are encouraged to submit studies concerning new potential biomarkers targetable for innovative therapeutic strategies and innovative evidence reporting new mechanisms or novel genetic as well as metabolic risk factors in psychiatric and neurologic disorders.
Dr. Carmela Matrone
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegeneration
- neurodevelopment
- biomarkers
- druggable targets
- neuroinflammation
- neuroimaging
- genetic risk factors
- metabolome
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.